Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FineCaRe: Finerenone in T2DM and CKD
NCT07026539Phase 4Recruiting
- Sponsor
- Aarhus University
- Start
- Oct 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of finerenone in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), sponsored by Aarhus University. Started Oct 2024; status: recruiting.
02
Drugs
finerenone
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT07026539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07026539.